Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001230724-26-000006
Filing Date
2026-03-02
Accepted
2026-03-02 20:08:11
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772500088.html 4  
1 FORM 4 wk-form4_1772500088.xml 4 10144
  Complete submission text file 0001230724-26-000006.txt   11692
Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address
GUGGENHIME ANDREW (Reporting) CIK: 0001230724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 26710552

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)